The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity
Open accessAbstract
B cell chronic lymphocytic leukemia (CLL) is a disease of expanding monoclonal B cells whose B cell receptor (BCR) mutational status defines 2 subgroups; patients with mutated BCRs have a more favorable prognosis than those with unmutated BCRs. CLL B cells express a restricted BCR repertoire including antibodies with quasi-identical complementarity-determining region 3 (CDR3), which suggests specific antigen recognition. The antigens recognized by CLL antibodies may include autoantigens since about half of CLL B cells produce autoreactive antibodies. However, the distribution of autoreactive antibodies between Ig heavy-chain variable-unmutated (IgV-unmutated) CLL (UM-CLL) and IgV-mutated CLL (M-CLL) is unknown. To determine the role of antibody reactivity and the impact of somatic hypermutation (SHM) on CLL antibody specificity, we cloned and expressed in vitro recombinant antibodies from M- and UM-CLL B cells and tested their reactivity by ELISA. We found that UM-CLL B cells expressed highly polyreactive antibodies whereas most M-CLL B cells did not. When mutated nonautoreactive CLL antibody sequences were reverted in vitro to their germline counterparts, they encoded polyreactive and autoreactive antibodies. We concluded that both UM-CLLs and M-CLLs originate from self-reactive B cell precursors and that SHM plays an important role in the development of the disease by altering original BCR autoreactivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., et al. (1999) · Blood · doi:10.1182/blood.v94.6.1840 · Cited by 2,642
Self-citationPredominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Self-citationClonal selection and learning in the antibody system
Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,709
Chiorazzi, N., Rai, K. R., & Ferrarini, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041720 · Cited by 1,296
Self-citationRosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1639 · Cited by 1,097
Self-citationKlein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1625 · Cited by 918
Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S. L., Schulman, P., Vinciguerra, V. P., Rai, K., Rassenti, L. Z., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3009 · Cited by 872
Self-citationMartin, F., & Kearney, J. F. (2002) · Nature Reviews Immunology · doi:10.1038/nri799 · Cited by 860
Weller, S. (2004) · Blood · doi:10.1182/blood-2004-01-0346 · Cited by 814
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E., Kudalkar, P., Cesar, D., Murphy, E. J., Koduru, P., Ferrarini, M., Zupo, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523409 · Cited by 599
Self-citationHuman Lymphocytes Making Rheumatoid Factor and Antibody to ssDNA Belong to Leu-1 + B-Cell Subset
Casali, P., Burastero, S. E., Nakamura, M., Inghirami, G., & Notkins, A. L. (1987) · Science · doi:10.1126/science.3105056 · Cited by 486
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.
Caligaris-Cappio, F., Gobbi, M., Bofill, M., & Janossy, G. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.2.623 · Cited by 469
Messmer, B. T., Albesiano, E., Efremov, D. G., Ghiotto, F., Allen, S. L., Kolitz, J., Foa, R., Damle, R. N., Fais, F., Messmer, D., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040544 · Cited by 443
Self-citationRheumatoid Factor Secretion from Human Leu-1 + B Cells
Hardy, R. R., Hayakawa, K., Shimizu, M., Yamasaki, K., & Kishimoto, T. (1987) · Science · doi:10.1126/science.3105057 · Cited by 440
Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K. R., Weiss, A., & Kipps, T. J. (2002) · Blood · doi:10.1182/blood-2002-06-1683 · Cited by 426
Chronic lymphocytic leukemia: revelations from the B-cell receptor
Stevenson, F. K., & Caligaris-Cappio, F. (2004) · Blood · doi:10.1182/blood-2003-12-4312 · Cited by 390
The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire
Schroeder, H. W., & Dighiero, G. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90009-4 · Cited by 385
B Cell Chronic Lymphocytic Leukemia: Lessons Learned from Studies of the B Cell Antigen Receptor
Chiorazzi, N., & Ferrarini, M. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141018 · Cited by 377
Self-citationLanham, S., Hamblin, T., Oscier, D., Ibbotson, R., Stevenson, F., & Packham, G. (2003) · Blood · doi:10.1182/blood-2002-06-1822 · Cited by 315
Sthoeger, Z. M., Wakai, M., Tse, D. B., Vinciguerra, V. P., Allen, S. L., Budman, D. R., Lichtman, S. M., Schulman, P., Weiselberg, L. R., & Chiorazzi, N. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.255 · Cited by 285
Self-citationAntibody regulation of B cell development
Meffre, E., Casellas, R., & Nussenzweig, M. C. (2000) · Nature Immunology · doi:10.1038/80816 · Cited by 283
Self-citationWidhopf, G. F., Rassenti, L. Z., Toy, T. L., Gribben, J. G., Wierda, W. G., & Kipps, T. J. (2004) · Blood · doi:10.1182/blood-2004-03-0818 · Cited by 251
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia
Ghiotto, F., Fais, F., Valetto, A., Albesiano, E., Hashimoto, S., Dono, M., Ikematsu, H., Allen, S. L., Kolitz, J., Rai, K. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19399 · Cited by 240
Self-citationKipps, T. J., Tomhave, E., Pratt, L. F., Duffy, S., Chen, P. P., & Carson, D. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5913 · Cited by 228
Development and function of B-1 cells
Hayakawa, K., & Hardy, R. R. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00098-4 · Cited by 221
Borche, L., Lim, A., Binet, J., & Dighiero, G. (1990) · Blood · doi:10.1182/blood.v76.3.562.562 · Cited by 220
Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features
Johnson, T. A., Rassenti, L. Z., & Kipps, T. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.235 · Cited by 216
ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia
Chen, L., Apgar, J., Huynh, L., Dicker, F., Giago-McGahan, T., Rassenti, L., Weiss, A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2004-05-1715 · Cited by 202
Damle, R. N., Batliwalla, F. M., Ghiotto, F., Valetto, A., Albesiano, E., Sison, C., Allen, S. L., Kolitz, J., Vinciguerra, V. P., Kudalkar, P., et al. (2004) · Blood · doi:10.1182/blood-2003-04-1345 · Cited by 182
Self-citationZupo, S., Isnardi, L., Megna, M., Massara, R., Malavasi, F., Dono, M., Cosulich, E., & Ferrarini, M. (1996) · Blood · doi:10.1182/blood.v88.4.1365.bloodjournal8841365 · Cited by 181
Ichiyoshi, Y., & Casali, P. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.885 · Cited by 156
Surrogate Light Chain Expressing Human Peripheral B Cells Produce Self-reactive Antibodies
Meffre, E., Schaefer, A., Wardemann, H., Wilson, P. C., Davis, R. E., & Nussenzweig, M. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031550 · Cited by 151
Self-citationBruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
Ng, Y.-S., Wardemann, H., Chelnis, J. G., Cunningham‐Rundles, C., & Meffre, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040920 · Cited by 147
Self-citationWidhopf, G. F., & Kipps, T. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.95 · Cited by 70
Cited by
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Self-citationRole of Bruton’s tyrosine kinase in B cells and malignancies
Pal Singh, S., Dammeijer, F., & Hendriks, R. W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0779-z · Cited by 726
From pathogenesis to treatment of chronic lymphocytic leukaemia
Zenz, T., Mertens, D., Küppers, R., Döhner, H., & Stilgenbauer, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2764 · Cited by 553
Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G., Smilevska, T., Belhoul, L., Stella, S., Stavroyianni, N., Crespo, M., et al. (2007) · Blood · doi:10.1182/blood-2006-03-012948 · Cited by 534
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Minden, M. D.-V., Übelhart, R., Schneider, D., Wossning, T., Bach, M. P., Buchner, M., Hofmann, D., Surova, E., Follo, M., Köhler, F., et al. (2012) · Nature · doi:10.1038/nature11309 · Cited by 504
Self-citation
Metadata
- Authors
- Hervé, M., Xu, K., Ng, Y.-S., Wardemann, H., Albesiano, E., Messmer, B. T., Chiorazzi, N., & Meffre, E.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1636-1643
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2051321376
- Cited by
- 338
- References
- 36
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.